PortfoliosLab logoPortfoliosLab logo
WDNA vs. NTSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

WDNA vs. NTSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WisdomTree BioRevolution Fund (WDNA) and WisdomTree U.S. Efficient Core Fund (NTSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, WDNA achieves a 15.26% return, which is significantly higher than NTSX's 7.28% return.


WDNA

1D
-2.29%
1M
-7.98%
6M
8.18%
YTD
15.26%
1Y
47.46%
3Y*
4.46%
5Y*
-4.37%
10Y*
ALL TIME*
-3.49%

NTSX

1D
0.71%
1M
-0.51%
6M
6.45%
YTD
7.28%
1Y
17.51%
3Y*
16.97%
5Y*
8.15%
10Y*
ALL TIME*
12.63%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.95M$1.79M$2.60M
$25.97K$30.05K$24.07K

WDNA vs. NTSX - Yearly Performance Comparison


2026 (YTD)20252024202320222021
WDNA
WisdomTree BioRevolution Fund
15.26%22.68%-14.18%-2.07%-26.29%-4.92%
NTSX
WisdomTree U.S. Efficient Core Fund
7.28%18.82%20.20%22.70%-25.84%12.70%

Correlation

The correlation between WDNA and NTSX is 0.51, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.51

Correlation (3Y)
Balances recent behavior with more history.

0.57

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.65

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2021

0.64

The correlation between WDNA and NTSX shifts across timeframes, from 0.51 (1 year) to 0.65 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

WDNA vs. NTSX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

WDNA
WDNA Risk / Return Rank: 8080
Overall Rank
WDNA Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
WDNA Sortino Ratio Rank: 8080
Sortino Ratio Rank
WDNA Omega Ratio Rank: 7272
Omega Ratio Rank
WDNA Calmar Ratio Rank: 9191
Calmar Ratio Rank
WDNA Martin Ratio Rank: 7474
Martin Ratio Rank

NTSX
NTSX Risk / Return Rank: 5252
Overall Rank
NTSX Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
NTSX Sortino Ratio Rank: 4848
Sortino Ratio Rank
NTSX Omega Ratio Rank: 4949
Omega Ratio Rank
NTSX Calmar Ratio Rank: 5050
Calmar Ratio Rank
NTSX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

WDNA vs. NTSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and WisdomTree U.S. Efficient Core Fund (NTSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


WDNANTSXDifference
Sharpe ratioReturn per unit of total volatility

+0.60

Sortino ratioReturn per unit of downside risk

+0.87

Omega ratioGain probability vs. loss probability

1.30

1.22

+0.08

Calmar ratioReturn relative to maximum drawdown

4.00

1.79

+2.21

Martin ratioReturn relative to average drawdown

9.29

7.28

+2.01

WDNA vs. NTSX - Sharpe Ratio Comparison

The current WDNA Sharpe Ratio is 1.84, which is higher than the NTSX Sharpe Ratio of 1.24. The chart below compares the historical Sharpe Ratios of WDNA and NTSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

WDNA vs. NTSX - Drawdown Comparison

The maximum WDNA drawdown since its inception was -58.87%, which is greater than NTSX's maximum drawdown of -31.34%. Use the drawdown chart below to compare losses from any high point for WDNA and NTSX.


Loading charts...

Drawdown Indicators


WDNANTSXDifference

Max Drawdown

Largest peak-to-trough decline

-58.87%

-31.34%

-27.53%

Max Drawdown (1Y)

Largest decline over 1 year

-11.70%

-9.16%

-2.54%

Max Drawdown (3Y)

Largest decline over 3 years

-36.65%

-16.82%

-19.83%

Max Drawdown (5Y)

Largest decline over 5 years

-58.87%

-31.34%

-27.53%

Current Drawdown

Current decline from peak

-25.81%

-2.27%

-23.54%

Average Drawdown

Average peak-to-trough decline

-35.30%

-6.70%

-28.60%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.03%

2.26%

+2.77%

Volatility

WDNA vs. NTSX - Volatility Comparison

WisdomTree BioRevolution Fund (WDNA) has a higher volatility of 7.04% compared to WisdomTree U.S. Efficient Core Fund (NTSX) at 3.82%. This indicates that WDNA's price experiences larger fluctuations and is considered to be riskier than NTSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


WDNANTSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.04%

3.82%

+3.22%

Volatility (6M)

Calculated over the trailing 6-month period

17.23%

10.74%

+6.49%

Volatility (1Y)

Calculated over the trailing 1-year period

25.54%

13.29%

+12.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.26%

17.20%

+8.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

25.04%

18.22%

+6.82%

WDNA vs. NTSX - Expense Ratio Comparison

WDNA has a 0.45% expense ratio, which is higher than NTSX's 0.20% expense ratio.


Dividends

WDNA vs. NTSX - Dividend Comparison

WDNA's dividend yield for the trailing twelve months is around 3.96%, more than NTSX's 1.10% yield.


PositionTTM20252024202320222021202020192018
NTSX
WisdomTree U.S. Efficient Core Fund
1.10%1.14%1.14%1.21%1.36%0.82%0.92%1.42%0.62%
WDNA
WisdomTree BioRevolution Fund
3.96%4.57%0.75%0.80%0.38%0.10%0.00%0.00%0.00%

Frequently Asked Questions


WDNA and NTSX have a correlation of 0.51, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

WDNA has higher volatility (7.04%) compared to NTSX (3.82%). In terms of maximum drawdown, WDNA dropped -58.87% vs NTSX's -31.34%.

On 5-year performance, NTSX leads with 8.15% vs -4.37% for WDNA. On fees, NTSX is cheaper at 0.20% per year. On volatility, NTSX has been the lower-risk option at 3.82%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, NTSX has performed better with a 8.15% return vs -4.37%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

NTSX is cheaper with a 0.20% expense ratio, compared with 0.45% for WDNA.

WDNA has the higher dividend yield at 3.96%, compared with 1.10% for NTSX.

WDNA is categorized as Health & Biotech Equities, while NTSX is Diversified Portfolio. Their fees differ too: 0.45% for WDNA and 0.20% for NTSX.

WDNA currently has the higher Sharpe Ratio (1.84 vs 1.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for WDNA and NTSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer